Entero Therapeutics to Change Name to GridAI and Switch Ticker to GRDX, Shares Rise 5%
ByAinvest
Friday, Nov 28, 2025 2:51 pm ET1min read
ENTO--
Entero Therapeutics' stock rose 5.28% to $2.99 after the company announced a name change to GridAI Technologies Corp. and ticker change to GRDX, effective December 1, 2025, following its acquisition of an AI-driven grid-edge software business. GridAI develops software for utilities and large power users to manage distributed energy resources and demand in real time. The name change reflects a strategic pivot from GI-disease focus to AI-powered energy infrastructure.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet